YTENQ Financials: Yield10 Bioscience Inc AI Analysis

Home

Stock

YTENQ

Financials

YTENQ Financial

Yield10 Bioscience Inc

-99%

$0

At close: Mar 24, 16:00:00 GMT-4

9,900%

$0

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0001

Open

$0.0001

Day's Range

$0.0001 - $0.0001

52 week range

$0.0001 - $0.015

Volume

1.5K

Avg.Volume

Dividend yield

EPS (TTM)

-126.37

Market Cap

$69

What is YTENQ?

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company is headquartered in Woburn, Massachusetts and currently employs 29 full-time employees. The company went IPO on 2006-11-10. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The firm is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

YTENQ Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	6	6	6	6	5	4
Research & Development	7	8	7	6	5	4
Operating Expenses	13	14	13	12	10	9
Other Non Operating Income (Expenses)	0	0	0	0	0	-1
Pretax Income	-12	-14	-13	-11	-10	-13
Income Tax Expense	--	0	0	0	0	0
Net Income	-12	-14	-13	-11	-10	-12
Net Income Growth	-14%	8%	18%	10%	-17%	33%
Shares Outstanding (Diluted)	0.64	0.33	4.91	4.73	2.37	0.36
Shares Change (YoY)	-89%	-93%	4%	100%	558%	44%
EPS (Diluted)	-19.77	-43.65	-2.76	-2.33	-4.3	-36
EPS Growth	697%	1,482%	18%	-46%	-88%	-2%
Free Cash Flow	-5	-10	-11	-9	-8	-8
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-12	-14	-13	-11	-9	-8
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-12	-14	-13	-11	-9	-8
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Follow-Up Questions

What are Yield10 Bioscience Inc's key financial statements?



According to the latest financial statement (Form-10K), Yield10 Bioscience Inc has a total asset of $3, Net loss of $-14

What are the key financial ratios for YTENQ?



Yield10 Bioscience Inc's Current ratio is 0.5, has a Net margin is 0, sales per share of $0.

How is Yield10 Bioscience Inc's revenue broken down by segment or geography?



Yield10 Bioscience Inc largest revenue segment is Specialty Oils and Niche Crops, at a revenue of 60,000 in the most earnings release.For geography, United States is the primary market for Yield10 Bioscience Inc, at a revenue of 60,000.

Is Yield10 Bioscience Inc profitable?



no, according to the latest financial statements, Yield10 Bioscience Inc has a net loss of $-14

Does Yield10 Bioscience Inc have any liabilities?



yes, Yield10 Bioscience Inc has liability of 6

How many outstanding shares for Yield10 Bioscience Inc?



Yield10 Bioscience Inc has a total outstanding shares of 0.5

Yield10 Bioscience Inc (YTENQ) Financial

YTENQ Stock Price Chart